Radar · Life Sciences Platforms and Tools in Paris
Best Life Sciences Platforms and Tools Companies in Paris, France
The 48 best Life Sciences Platforms and Tools companies in Paris, France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: DNA Script.
By Rohit KhannaTrends & Stories
48companies tracked
$749.3Mdisclosed funding
0unicorns
32have raised
FLIAR INTELLIGENCE · LIFE SCIENCES PLATFORMS AND TOOLS × PARIS
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
50companies analysed
68%cloud-native stacks
2025funding peak (by rounds)
2unicorns
2013median founding year
170kcombined LinkedIn audience
33%of audience held by top 3
4companies hiring publicly (12 mo)
Ranked: Best Life Sciences Platforms and Tools companies in Paris
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DNA Script Developer of benchtop DNA printer for nucleic acid synthesis | $315M | 35 mo ago | Series C | Xavier Godron Co-founder & CTO | 2014 | WordPress Block EditorWordPressBugHerd+30 | 334 patents Patents concentrated in chemistry & materials | — |
| 2 | HiFiBiO Provider of a technology platform for the discovery of antibody-based drugs | $180M | 62 mo ago | Series D | Liang Schweizer Founder | 2013 | — | 36 patents Patents concentrated in chemistry & materials | — |
| 3 | AFYREN Provider of analytical services for microbiology, chemistry and bioprocesses industries 40Funding top 25%Talent top 28%Moat top 35%Patents top 37% All 11 signals ▾Fundingtop 25% Talenttop 28% Moattop 35% Patentstop 37% Techtop 43% Innovationtop 48% Growthtop 48% Newsbottom 49% Globalbottom 40% Marketbottom 32% Fin. healthbottom 20% Funding: Raised $96.9M across 7 rounds · 7 rounds over 11 yrs (0.6/yr) Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 40/100 | $97M | 3 mo ago | Public | Regis Nouaille Co-Founder | 2012 | WordPress Site EditorWordPressMySQL+24 | 118 patents Recovery and purification of potassium salts and metabolites from anaerobic fermentation processes | — |
| 4 | Qubit Pharmaceuticals Developer of drugs for the treatment of cancer and inflammatory diseases | $25M | 47 mo ago | Seed | Jay Ponder Co-Founder | 2020 | WebflowApple iCloud MailGoogle Workspace+14 | 15 patents Quantum algorithms for molecular simulation and optimized quantum circuit design for chemistry | — |
| 5 | Metafora Biosystems Provider of diagnostic tests and reagents for research | $23M | 43 mo ago | Funding Raised | Luc Dauriol Co-Founder & Chairman | 2011 | — | 37 patents Diagnostic biomarkers and computational tools for single‑cell analysis in hematology | — |
| 6 | Astraveus Provider of a device for autologous cell and gene therapies | $18M | 19 mo ago | Seed | Jeremie Laurent Founder & CEO | 2016 | WordPressMySQLPHP+25 | 51 patents Patents concentrated in transport & manufacturing processes | — |
| 7 | Core Biogenesis Provider of UBaaS platform for recombinant protein bioproduction | $14M | 52 mo ago | Series A | Chouaib Meziadi CSO | 2020 | — | 9 patents Patents concentrated in chemistry & materials | — |
| 8 | Meiogenix Developer of novel breeding technologies for crop plants | $13M | 56 mo ago | Series A | Luc Mathis CEO | 2010 | WebflowGSAPMicrosoft Advertising+10 | 39 patents CRISPR‑based tools for engineered meiotic recombination and genome editing | — |
| 9 | Okomera Developer of a device for in vitro cancer testing using a microfluidic chip | $11M | 31 mo ago | Seed | Aimee Wessel Co-Founder & CEO | 2020 | Webflow EcommerceWebflowPlausible+7 | 2 patents Microfluidic droplet generation and collection devices for precise fluid handling | — |
| 10 | Aenitis Developer of acoustic based tools for cell sorting | $10M | 61 mo ago | Funding Raised | Emmanuel VINCENT Co-Founder & CEO | 2014 | — | — | — |
| 11 | Spore Biotechnologies Developer of microbial detection technology for life science industries 53AI top 15%Growth top 35%Talent top 38%Funding top 42% All 10 signals ▾AItop 15% Growthtop 35% Talenttop 38% Fundingtop 42% Moattop 42% Techtop 43% Patentstop 46% Innovationbottom 47% Globalbottom 39% Marketbottom 23% AI: Holds AI/ML patents (G06N-family CPC) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 53/100 | $9M | 7 mo ago | Series A | Amine Raji Co-Founder & CEO | 2022 | RubyAnimate.cssTailwind CSS+12 | 7 patents Rapid optical detection of bacteria in samples using spectroscopic sensor technology | 1 job opening · 1 award |
| 12 | Scipio Bioscience Develops sample preparation solutions | $8M | 37 mo ago | Series A | Pierre Walrafen Co-Founder & CEO | 2017 | — | 19 patents Hydrogel-based spatial omics platforms for single-cell capture and barcoding | — |
| 13 | One Biosciences Developer of single-cell therapeutics solutions to treat multiple health disorders | $5M | 12 mo ago | Series A | Celine Vallot Co-Founder | 2020 | WordPressMySQLPHP+7 | — | 1 partnership · 2 awards |
| 14 | Elveflow Developer of flow control systems | $4M | 57 mo ago | Funding Raised | Eric Farin CEO | 2011 | WordPressMySQLRedis+31 | — | — |
| 15 | Inorevia Developer of microfluidics platform | $3M | 50 mo ago | Funding Raised | Laurent Malaquin Co-Founder | 2016 | — | 8 patents Microfluidic droplet manipulation, sorting, and individual droplet extraction technologies. | — |
| 16 | Eden Tech Provider of microfabrication solutions for bioinspired microfluidics technologies | $2M | 56 mo ago | Funding Raised | Emmanuel Roy Co-Founder & CEO | 2017 | WordPressMySQLPHP+31 | — | 1 launch |
| 17 | Abbelight Provider of solutions for microscopes, reagents, and software for image analysis 57AI top 15%Product top 30%Moat top 32%Innovation top 40% All 9 signals ▾AItop 15% Producttop 30% Moattop 32% Innovationtop 40% Patentstop 40% Fundingtop 42% Techbottom 48% Marketbottom 42% Globalbottom 36% AI: Holds AI/ML patents (G06N-family CPC) Product: 4 distinct product lines · Company stage: Series B rank vs industry peers · Fliar Intelligence Index 57/100 | $2M | 7 mo ago | Series B | — | 2015 | WordPressMySQLPHP+19 | 24 patents Super-resolution single-molecule fluorescence microscopy hardware and image‑saving methods | 2 awards |
| 18 | CryoCap cells Manufactures sample preparation systems for electron microscope | $2M | 114 mo ago | Seed | — | 2013 | — | — | — |
| 19 | Minos Biosciences Developer of a sequencing-based multi-omic analysis device | $2M | 63 mo ago | Seed | Hubert Geisler Co-founder & Head of Microfluidics | 2020 | — | — | — |
| 20 | GreenTropism Provider of software components for mainstream and industrial spectroscopy | $1M | 108 mo ago | Seed | Anthony Boulanger Founder & CEO | 2014 | — | 31 patents Rapid pathogen detection in biological fluids using surface-enhanced Raman spectroscopy | — |
| 21 | EVerZom Developer of a technology platform for the production of extracellular vesicles | $1M | 13 mo ago | Seed | Max Piffoux Co-Founder & CTO | 2018 | WordPress Block EditorWordPressMySQL+18 | — | — |
| 22 | Alveole Developer of device for in vitro cell microenvironment model | $1M | 93 mo ago | Seed | Romuald Vally CEO | 2010 | — | 46 patents Biofabrication of patterned hydrogels and proteins with large-field 3D spectral microscopy | — |
| 23 | Millidrop Provider of cell culture machines based on milli fluidics technology for bacteriological research | $1M | 95 mo ago | Seed | — | 2015 | — | — | — |
| 24 | Phenocell Provider of cell-based assays for drug discovery | $942K | 127 mo ago | Acquired | — | 2013 | — | 2 patents Deriving human sebocyte precursor cells from iPSCs for dermatological cell therapy | — |
| 25 | Xentech Patient-Derived tumor Xenograft patform offering preclinical cancer models and services for translational… | $765K | 127 mo ago | Seed | — | 2006 | — | 10 patents Predictive cancer biomarker diagnostics for chemotherapy and PARP inhibitor response | — |
| 26 | Glowee Provider of bioluminescent lighting solutions | $678K | 38 mo ago | Seed | Sandra Rey Founder & CEO | 2014 | WordPressMySQLPHP+17 | 10 patents Engineered bioluminescent proteins and bacterial systems for sustainable lighting of façades and decorative panels. | — |
| 27 | Elvesys Microfluidics Manufacturer of microfluidic instruments for flow control, measurement, and detection | $638K | 115 mo ago | Funding Raised | — | 2011 | — | — | 1 job opening · 1 partnership |
| 28 | Kolibri Developer of acoustic wave-based bioreactors to handle mammalian cells | $250K | 35 mo ago | Seed | Gabriel dumy Co-Founder | 2020 | — | 3 patents Acoustic microfluidic cell culture platforms for compartmentalized tissue engineering | — |
| 29 | Microfactory Microfluidic devices for research | $121K | 102 mo ago | Funding Raised | Fabrice Monti Co-Founder | 2014 | — | 30 patents Hydrogel-based 3D cell/organelles analysis and skin-mimetic testing platforms | — |
Top 12 Life Sciences Platforms and Tools companies in Paris
#1
Public · Paris, Ile de France · founded 2012 · 32 employees$96.9Mraised▾
Public · Paris, Ile de France · founded 2012 · 32 employees
Provider of analytical services for microbiology, chemistry, and bioprocesses industries. It has developed its product known as Afynerie, technology, which directly valorizes non-food biomass (wastes) into biomolecules of high energetical and chemical interest. The company offers services including the measurement of methane volume (or more generally biogas) produced by degradation of organic substrates by anaerobic microorganisms, & organic substrates physicochemical characterization.
Fliar Intelligence Index™ 40how this company ranks against its industry peers
Funding
top 25%Talent
top 28%Moat
top 35%Patents
top 37%Tech
top 43%Innovation
top 48%Funding: Raised $96.9M across 7 rounds · 7 rounds over 11 yrs (0.6/yr) · Last round Grant (prize money) (Apr 2026)
Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 5/10 · IP moat: 118 patents · 9 curated direct competitors tracked
Audience (LinkedIn): 20k LinkedIn followers — 11.6% of this cohort's audience · 57 engagements/post (2.2× cohort median)
Funding rounds
- Apr 2026Grant (prize money)$3.5M
- Feb 2026Post IPO$8.2M
- Nov 2025Post IPO$26.6M
- Jul 2025Grant (prize money)$4.7M
Founders & team
Investors
JEREMIE AUVERGNE, Valquest Capital Management, Sofinnova Partners, Bpifrance, Kemin, Odyssee Venture
Tech stack
Apache Http ServerComplianzContact Form 7Core-JsDropzoneFormidable Form
#2
Series A · Paris, Ile de France · founded 2022 · 5 employees$8.6Mraised▾
Series A · Paris, Ile de France · founded 2022 · 5 employees
Developer of microbial detection technology for life science industries. The company is developing innovative technologies to detect bacterial and microbial risk for various industries food&beverage, cosmetics, and pharmaceutics manufacturers.
Fliar Intelligence Index™ 53how this company ranks against its industry peers
AI
top 15%Growth
top 35%Talent
top 38%Funding
top 42%Moat
top 42%Tech
top 43%AI: Holds AI/ML patents (G06N-family CPC)
Growth: Fresh capital in last 24 mo
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Audience (LinkedIn): 13k LinkedIn followers — 7.4% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Senior Computer Vision Data Scientist
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Jan 2026Grant (prize money)—
- Feb 2025Series A$23M
- Dec 2023Seed$8.6M
Founders & team
Investors
LocalGlobe, EmergingTech Ventures, No Label Ventures, Family C Venture, Better Angle, Singular
Tech stack
Animate.CssCloudflareFont AwesomeGoogle Font ApiGoogle Hosted LibrariesGoogle Workspace
#3
Series B · Paris, Ile de France · founded 2015 · 42 employees$2.1Mraised▾
Series B · Paris, Ile de France · founded 2015 · 42 employees
Abbelight provides microscopes, reagents, and software for image analysis. Their 3D fluorescence nanoscopy products include Single Molecule Localization Microscopy (SMLM), high-throughput 2D single-molecule and TIRF imaging, and 3D single-molecule and multi-color imaging. The company also offers smart kits and reagents (dyes) for research use and software that allows the production and manipulation of 3D quantitative data.
Fliar Intelligence Index™ 57how this company ranks against its industry peers
AI
top 15%Product
top 30%Moat
top 32%Innovation
top 40%Patents
top 40%Funding
top 42%AI: Holds AI/ML patents (G06N-family CPC)
Product: 4 distinct product lines · Company stage: Series B
Moat: Editorial + unicorn rating 4/10 · IP moat: 24 patents
Audience (LinkedIn): 5k LinkedIn followers — 3.0% of this cohort's audience
Activity (LinkedIn): 2 awards announced in 12 mo
Funding rounds
- Jan 2026Series B—
- Jul 2023Grant (prize money)$600.7K
- Apr 2022Grant (prize money)$52.7K
- May 2020Grant (prize money)$1.3M
Investors
EIC Fund, Europa, AVANT BIO, Pleiade Venture
Tech stack
Apache Http ServerCloudflareCloudflare Bot ManagementGoogle AnalyticsGoogle Font ApiHttp/3
#4
Seed · Paris, Ile de France · founded 2016 · 29 employees$18Mraised▾
Seed · Paris, Ile de France · founded 2016 · 29 employees
Provider of a device for autologous cell and gene therapies. The company focuses on building high-tech equipment to manufacture autologous cell and gene therapies which include CAR-T or stem cell treatments. The company has developed Lakhesys a microfluidic technology to develop cellular therapies for various disease conditions.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 3.8% of this cohort's audience
Funding rounds
- Dec 2024Grant (prize money)$7.4M
- Oct 2023Grant (prize money)$1.1M
- Jun 2023Seed$18M
- Feb 2022Grant (prize money)$56.3K
Founders & team
Investors
Government of France, EIC Fund, Europa, AdBio partners, M Ventures, Johnson & Johnson Innovation
Tech stack
Apache Http ServerBabelCloudflareCloudflare Bot ManagementComplianzCore-Js
#5
Series A · Paris, Ile de France · founded 2020$5Mraised▾
Series A · Paris, Ile de France · founded 2020
Developer of single-cell therapeutics solutions to treat multiple health disorders. The company's proprietary platform uses single-cell RNA and DNA sequencing that helps to analyze disease-causing agents and provides treatment solutions. The company has developed single-cell computational software for the analysis of genomic data.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 8k LinkedIn followers — 4.5% of this cohort's audience
Activity: 1 partnerships · 2 awards · 1 expansions (incl. Guddine Roussy) announced in 12 mo
Funding rounds
- Jul 2025Series A$17.4M
- Sep 2022Series A$5M
Founders & team
Investors
Galion.exe, Invus, Adamed, Sofinnova Investments, Polytechnique Ventures, Kima Ventures
Tech stack
FlywheelGsapMicrosoft 365MysqlOpen GraphOvhcloud
#6
Series C · Paris, Ile de France · founded 2014 · 202 employees$315Mraised▾
Series C · Paris, Ile de France · founded 2014 · 202 employees
DNA script is a developer of a benchtop DNA printer powered by enzymatic technology for nucleic acid syntheis. It is offering a benchtop DNA printer that provides outsourced chemical-based DNA synthesis through enzymatic synthesis technology to synthesize DNA.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 24k LinkedIn followers — 14.0% of this cohort's audience
Funding rounds
- Sep 2023Grant (prize money)$4.3M
- Jan 2022Series C$35M
- Oct 2021Series C$165M
- Sep 2021Grant (prize money)$280K
Founders & team
Investors
Europa, EIC Fund, DARPA, eureKARE, T. Rowe Price, Baillie Gifford
Tech stack
AosBootstrapBugherdCloudflareCloudflare Bot ManagementFancybox
#7
Seed · Paris, Ile de France · founded 2018 · 17 employees$1.3Mraised▾
Seed · Paris, Ile de France · founded 2018 · 17 employees
EVerZom develops a technology platform for the production of extracellular vesicles. The extracellular vesicles are generated by Mesenchymal stem cells having regenerative properties. This method can be used to apply turbulence stimulation to cells.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 7k LinkedIn followers — 4.1% of this cohort's audience
Activity: 1 partnerships (incl. GENFIT) announced in 12 mo
Funding rounds
- Jun 2025Grant (prize money)$3.5M
- Jun 2022Grant (prize money)$118.7K
- May 2022Grant (prize money)$1.8M
- Nov 2021Grant (prize money)$3.4M
Founders & team
Investors
EIC Fund, Europa, Bpifrance, Erganeo
Tech stack
CloudflareCloudflare Bot ManagementComplianzGoogle Font ApiHstsHttp/3
#8
Series D · Paris, Ile de France · founded 2013 · 75 employees$179.5Mraised▾
Series D · Paris, Ile de France · founded 2013 · 75 employees
Provider of a technology platform for the discovery of antibody-based drugs. The platform combines high throughput, single-cell, functional-based screening of entire B cell (Ab producing cells) populations with next-generation sequencing and rapid DNA synthesis for rare antibody drugs.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 10k LinkedIn followers — 5.9% of this cohort's audience
Funding rounds
- Jun 2021Series D$75M
- Aug 2019Series C$67M
- May 2018Series B$37.5M
- Series A—
Founders & team
Investors
Sequoia Capital, Sherpa Healthcare Partners, Maison Capital, Grand Mount Capital, HKSTP, TIF
Tech stack
Master SliderWordpressMysqlPhpZurb FoundationGravity Forms
#9
Funding Raised · Paris, Ile de France · founded 2011 · 32 employees$22.7Mraised▾
Funding Raised · Paris, Ile de France · founded 2011 · 32 employees
Metafora biosystems offers diagnostic tests and research reagents (IVD platform for drug discovery, development). They have developed few probes called RBDs which attaches to the transporters to analyze their quantity. Using the technology they have developed METAglut1 blood test to diagnose the GLUT1 deficiency syndrome (GLUT1 DS) which happens because of impairment of the major glucose transporter 1. It has an ability to target nutrient transporters at the cell surface.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers
Funding rounds
- Jan 2023Grant (prize money)$2.7M
- Oct 2022Grant (prize money)$8.5M
- Jun 2020Grant (prize money)$3.6M
- Jun 2018Grant (prize money)$3.8M
Founders & team
Investors
EIC Fund, Europa, BigBooster
Tech stack
WordpressMysqlPhpGoogle MapsWpbakeryApache Http Server
#10
Seed · Paris, Ile de France · founded 2020 · 15 employees$11.2Mraised▾
Seed · Paris, Ile de France · founded 2020 · 15 employees
Developer of a device for in vitro cancer testing using a microfluidic chip. The company's proprietary technology can be used for personalised treatment and testing of cancer cells in 3D spheroids. It is used for the study of tumour biopsy.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 9k LinkedIn followers — 5.4% of this cohort's audience
Funding rounds
- Dec 2023Seed$11.2M
Founders & team
Investors
Polytechnique Ventures, Berkeley SkyDeck Fund, Resonance, Otium Capital, Berkeley SkyDeck, Village Capital
#11
Seed · Paris, Ile de France · founded 2020 · 50 employees$24.6Mraised▾
Seed · Paris, Ile de France · founded 2020 · 50 employees
Developer of drugs for the treatment of cancer and inflammatory diseases. The company uses software and AI-enhanced medicinal chemistry to develop novel drug candidates in the areas of oncology, inflammation, and pandemics response.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 12k LinkedIn followers — 7.0% of this cohort's audience
Activity: 2 partnerships (incl. Centre for Quantum Technologies) announced in 12 mo
Funding rounds
- Sep 2022Grant (prize money)$2.5M
- Jun 2022Seed$17.2M
- Jun 2020Grant (prize money)—
Founders & team
Investors
XAnge, Quantonation, Omnes Capital, EIT Health, EIC Fund
Tech stack
Apple Icloud MailCdnjsCloudflareGoogle Font ApiGoogle Hosted LibrariesGoogle Workspace
#12
Series A · Paris, Ile de France · founded 2017 · 44 employees$7.9Mraised▾
Series A · Paris, Ile de France · founded 2017 · 44 employees
Scipio Bioscience is engaged in the development of sample preparation solutions for single-cell studies, in the form of benchtop kits, for use in sequencing applications in clinical and basic research, in particular, transcriptomics.
Funding rounds
- 2023Grant (prize money)—
- Feb 2020Series A$6.5M
- Nov 2017Seed$1.4M
Founders & team
Investors
M Ventures, Seventure Partners, Financiere Arbevel, HTGF, Verve Ventures, EIC Fund
Tech stack
WordpressMysqlPhpBootstrapAnimate.CssWp Rocket
Funding & investor landscape
$749.3Mtotal disclosed funding
30companies funded
104disclosed rounds
0rounds last 90 days
Most active investors
Bpifrance6 rounds
Notable founders
Regis Nouaille
Co-Founder · AFYREN
Nicolas Sordet
Founder & CEO · AFYREN
Amine Raji
Co-Founder & CEO · Spore Biotechnologies
Maxime Mistretta
Co-founder & CTO · Spore Biotechnologies
Jeremie Laurent
Founder & CEO · Astraveus
Celine Vallot
Co-Founder · One Biosciences
David Schilansky
Co-Founder · One Biosciences
Xavier Godron
Co-founder & CTO · DNA Script
Max Piffoux
Co-Founder & CTO · EVerZom
Jeanne Volatron
Co-Founder & CEO · EVerZom
Liang Schweizer
Founder · HiFiBiO
Luc Dauriol
Co-Founder & Chairman · Metafora Biosystems
Prism market signals · France · country-scoped Prism corpus, 2,902,929 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH IN PARIS · Health & Bio
How research on Bioinformatics in Paris is moving
A read on the academic research around Bioinformatics in Paris — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 336 papers.
336 papers · stance +0.46 · 49% breakthrough · 20% concern
top institutions
- Assistance Publique – Hôpitaux de Paris112
- Université Paris Cité64
- Université Paris-Saclay55
- AgroParisTech37
- CEA Paris-Saclay33
leading researchers
Valentin Sorin · Maulana M. Naji · Aurélien Capitan · Cécile Grohs · F. Besnard · Julie Aubert
prism intelligence · tone & topics
90% positive · 2% critical tone
Medical ResearchBiotechnologyHealthBiologyPharmaceuticalsGenetics
▲
Breakthroughs137 · 41%
▲ 37%→42% share
▲1.1× share momentum0 median citations91% since 2021mostly methods-led
Breakthroughs are rising (37%→42% of field), led by Gene.
rising sub-themes (early→recent)
- Gene1→15
- Transcriptome1→15
- Gene expression profiling1→7
- Immune system1→5
- Identification (biology)1→4
Newly emergingDisease 0→13 · Genome 0→11 · Phenotype 0→9
Landmark ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks · 6,609 cites
◆
Advancements86 · 26%
▲ 22%→25% share
▲1.1× share momentum0 median citations85% since 2021mostly empirical
Advancements are rising (22%→25% of field), led by Transcriptome.
rising sub-themes (early→recent)
- Transcriptome1→6
- Microbiome1→3
- Gene3→5
Newly emergingDisease 0→9 · Immune system 0→6 · Context (archaeology) 0→5
Landmark Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors · 5,249 cites
▼
Concerns56 · 17%
▼ 19%→17% share
▼0.9× share momentum0 median citations89% since 2021mostly empirical
Concerns are cooling (19%→17% of field), led by Disease.
rising sub-themes (early→recent)
- Disease8
- Gene6
- Identification (biology)5
- Metagenomics4
- Computational biology3
Newly emergingDisease 0→7 · Gene 0→6 · Metagenomics 0→4
Landmark A standardised staticin vitrodigestion method suitable for food – an international consensus · 5,317 cites
Common questions
How many Life Sciences Platforms and Tools companies are there in Paris, France?
Radar tracks 48 indexable Life Sciences Platforms and Tools companies headquartered in Paris, France that meet our profile-completeness bar.
What is the total funding raised by Life Sciences Platforms and Tools companies in Paris, France?
The Life Sciences Platforms and Tools companies in Paris, France on this list have raised a combined $749.3M in disclosed equity funding across 30 funded companies.
Which is the highest-funded Life Sciences Platforms and Tools company in Paris, France?
DNA Script is the highest-funded Life Sciences Platforms and Tools company in Paris, France, with $315M in disclosed equity funding.
How many Life Sciences Platforms and Tools companies in Paris, France are funded?
30 of the 48 Life Sciences Platforms and Tools companies in Paris, France on this list have disclosed at least one equity funding round.
How many Life Sciences Platforms and Tools unicorns are there in Paris, France?
None of the Life Sciences Platforms and Tools companies in Paris, France on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Paris, France Life Sciences Platforms and Tools companies?
The most active investors in Paris, France Life Sciences Platforms and Tools companies on this list include Europa, EIC Fund, Bpifrance, EIT Health, Entrepreneur First.
Rohit KhannaTrends & Stories
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.